These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35813427)

  • 21. The evolution of melasma therapy: targeting melanosomes using low-fluence Q-switched neodymium-doped yttrium aluminium garnet lasers.
    Kauvar AN
    Semin Cutan Med Surg; 2012 Jun; 31(2):126-32. PubMed ID: 22640433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of refractory dermal melasma with the MedLite C6 Q-switched Nd:YAG laser: two case reports.
    Polnikorn N
    J Cosmet Laser Ther; 2008 Sep; 10(3):167-73. PubMed ID: 18788035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laser therapy in the treatment of melasma: a systematic review and meta-analysis.
    Lai D; Zhou S; Cheng S; Liu H; Cui Y
    Lasers Med Sci; 2022 Jun; 37(4):2099-2110. PubMed ID: 35122202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using reflectance confocal microscopy to observe in vivo melanolysis after treatment with the picosecond alexandrite laser and Q-switched Nd:YAG laser in melasma.
    Jo DJ; Kang IH; Baek JH; Gwak MJ; Lee SJ; Shin MK
    Lasers Surg Med; 2019 Jul; 51(5):423-429. PubMed ID: 30351494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative study of fractional Erbium: YAG laser vs combined therapy with topical steroid as an adjuvant treatment in melasma.
    Abdel-Raouf Mohamed H; Ali Nasif G; Saad Abdel-Azim E; Abd El-Fatah Ahmed M
    J Cosmet Dermatol; 2019 Apr; 18(2):517-523. PubMed ID: 30146730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A split face study to document the safety and efficacy of clearance of melasma with a 5 ns q switched Nd YAG laser versus a 50 ns q switched Nd YAG laser.
    Alsaad SM; Ross EV; Mishra V; Miller L
    Lasers Surg Med; 2014 Dec; 46(10):736-40. PubMed ID: 25411141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparative study on efficacy of high and low fluence Q-switched Nd:YAG laser and glycolic acid peel in melasma.
    Kar HK; Gupta L; Chauhan A
    Indian J Dermatol Venereol Leprol; 2012; 78(2):165-71. PubMed ID: 22421647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Q-switched Nd: YAG laser versus trichloroacetic acid peeling in the treatment of melasma among Egyptian patients.
    Moubasher AE; Youssef EM; Abou-Taleb DA
    Dermatol Surg; 2014 Aug; 40(8):874-82. PubMed ID: 25068546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Study of a Q-Switched Neodymium-Doped Yttrium Aluminum Garnet Laser with Different Parameters in the Treatment of Chloasma: A Randomized-Controlled Trial.
    Pan J; Zhao JH; Lv YW; Zeng SW; Zhao JY; Gao FL
    Photobiomodul Photomed Laser Surg; 2022 Mar; 40(3):183-188. PubMed ID: 35298285
    [No Abstract]   [Full Text] [Related]  

  • 30. Combining Low Power Fractional CO
    Esmat S; Z Elramly A; Shahin D; Hilal RF
    Lasers Surg Med; 2021 Dec; 53(10):1325-1340. PubMed ID: 34164829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Riehl melanosis treated successfully with Q-switch Nd:YAG laser.
    Smucker JE; Kirby JS
    J Drugs Dermatol; 2014 Mar; 13(3):356-8. PubMed ID: 24595582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and Safety of Topical Silymarin Versus Low Fluence 1064-nm Q Switched Nd:YAG Laser in the Treatment of Melasma: A Comparative Randomized Trial.
    Ibrahim SMA; Farag AS; Ali MS; El-Gendy WMAF
    Lasers Surg Med; 2021 Dec; 53(10):1341-1347. PubMed ID: 34101206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disorders of hyperpigmentation. Part II. Review of management and treatment options for hyperpigmentation.
    Ko D; Wang RF; Ozog D; Lim HW; Mohammad TF
    J Am Acad Dermatol; 2023 Feb; 88(2):291-320. PubMed ID: 35158001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of Picosecond Laser for Melasma Treatment: A Narrative Review.
    Pimentel B; Palmeiro A; Castro C; Silva L; Catorze MG; João AL
    Photobiomodul Photomed Laser Surg; 2023 Dec; 41(12):674-682. PubMed ID: 38085187
    [No Abstract]   [Full Text] [Related]  

  • 35. A comparative study of low-fluence 1064-nm Q-switched Nd:YAG laser with or without chemical peeling using Jessner's solution in melasma patients.
    Lee DB; Suh HS; Choi YS
    J Dermatolog Treat; 2014 Dec; 25(6):523-8. PubMed ID: 24289244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and Safety of Picosecond Laser in the Treatment of Melasma: A Network Meta-analysis.
    Ren R; Bao S; Qian W; Zhao H
    Dermatol Surg; 2023 May; 49(5S):S49-S55. PubMed ID: 37116000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of the 1064-nm Q-switched Nd:YAG laser in melasma.
    Suh KS; Sung JY; Roh HJ; Jeon YS; Kim YC; Kim ST
    J Dermatolog Treat; 2011 Aug; 22(4):233-8. PubMed ID: 20443754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Melanocyte activation and skin barrier disruption induced in melasma patients after 1064 nm Nd:YAG laser treatment.
    Gao YL; Jia XX; Wang M; Hua Y; Zheng H; Xiang WZ; Song XZ
    Lasers Med Sci; 2019 Jun; 34(4):767-771. PubMed ID: 30302596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of melasma with topical agents, peels and lasers: an evidence-based review.
    Rivas S; Pandya AG
    Am J Clin Dermatol; 2013 Oct; 14(5):359-76. PubMed ID: 23881551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Melasma treatment using an erbium:YAG laser: a clinical, immunohistochemical, and ultrastructural study.
    Attwa E; Khater M; Assaf M; Haleem MA
    Int J Dermatol; 2015 Feb; 54(2):235-44. PubMed ID: 25266556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.